Kontinuierliche β-Blockade mit Esmolol in Kombination mit Enoximon-Gabe View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-02-14

AUTHORS

S. Suttner, J. Boldt, K. Lang, J. Mayer, K. Röhm, S.N. Piper

ABSTRACT

BackgroundThe aim of this study was to assess cardiac function in vascular surgery patients with known coronary artery disease (CAD) who received continuous perioperative beta blocker therapy with esmolol alone versus esmolol in combination with the phosphodiesterase (PDE) III inhibitor enoximone.Patients and methodsOver a period of 24 h, 28 patients were assigned to receive heart rate (HR) control by continuous infusion of esmolol in combination with the PDE III inhibitor enoximone (Esmolol+Enoximone group) or esmolol alone (Esmolol group; n=14). Cardiac function was assessed by the use of a pulmonary artery catheter and serial measurements of plasma troponin T (TnT) und B-type natriuretic peptide (BNP).ResultsThe heart rate significantly decreased to the target rate of 50–60 min−1 in both groups over the observation period. Cardiac index increased significantly only in Esmolol+Enoximone-treated patients (from 2.4±0.2 l×min−1×m−2 to 3.1±0.1 l×min−1×m−2) and was significantly higher than in the esmolol alone group (from 2.5±0.2 l×min−1×m−2 to 2.4±0.1 l×min−1×m−2). No patient had detectable levels of cTnT perioperatively. Peak plasma BNP concentrations were significantly increased in both groups but the highest values were measured in the esmolol alone group.ConclusionInotropic therapy with the PDE III inhibitor enoximone improves cardiac function in high risk patients with known CAD undergoing vascular surgery and also when receiving systematic heart rate control by continuous infusion of esmolol. More... »

PAGES

231-241

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00101-008-1313-2

DOI

http://dx.doi.org/10.1007/s00101-008-1313-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051434526

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18270676


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anesthesia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Natriuretic Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiotonic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Electrocardiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enoximone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Monitoring, Intraoperative", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphodiesterase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propanolamines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Troponin T", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Surgical Procedures", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suttner", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boldt", 
        "givenName": "J.", 
        "id": "sg:person.01230376335.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230376335.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lang", 
        "givenName": "K.", 
        "id": "sg:person.01114147735.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114147735.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mayer", 
        "givenName": "J.", 
        "id": "sg:person.01177053013.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177053013.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00f6hm", 
        "givenName": "K.", 
        "id": "sg:person.0770704460.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770704460.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland", 
          "id": "http://www.grid.ac/institutes/grid.413225.3", 
          "name": [
            "Klinik f\u00fcr An\u00e4sthesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piper", 
        "givenName": "S.N.", 
        "id": "sg:person.0737003120.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737003120.38"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2008-02-14", 
    "datePublishedReg": "2008-02-14", 
    "description": "BackgroundThe aim of this study was to assess cardiac function in vascular surgery patients with known coronary artery disease (CAD) who received continuous perioperative beta blocker therapy with esmolol alone versus esmolol in combination with the phosphodiesterase (PDE) III inhibitor enoximone.Patients and methodsOver a period of 24\u00a0h, 28 patients were assigned to receive heart rate (HR) control by continuous infusion of esmolol in combination with the PDE\u00a0III inhibitor enoximone (Esmolol+Enoximone group) or esmolol alone (Esmolol group; n=14). Cardiac function was assessed by the use of a pulmonary artery catheter and serial measurements of plasma troponin T (TnT) und B-type natriuretic peptide (BNP).ResultsThe heart rate significantly decreased to the target rate of 50\u201360\u00a0min\u22121 in both groups over the observation period. Cardiac index increased significantly only in Esmolol+Enoximone-treated patients (from 2.4\u00b10.2\u00a0l\u00d7min\u22121\u00d7m\u22122 to 3.1\u00b10.1\u00a0l\u00d7min\u22121\u00d7m\u22122) and was significantly higher than in the esmolol alone group (from 2.5\u00b10.2\u00a0l\u00d7min\u22121\u00d7m\u22122 to 2.4\u00b10.1\u00a0l\u00d7min\u22121\u00d7m\u22122). No patient had detectable levels of cTnT perioperatively. Peak plasma BNP concentrations were significantly increased in both groups but the highest values were measured in the esmolol alone group.ConclusionInotropic therapy with the PDE\u00a0III inhibitor enoximone improves cardiac function in high risk patients with known CAD undergoing vascular surgery and also when receiving systematic heart rate control by continuous infusion of esmolol.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00101-008-1313-2", 
    "inLanguage": "de", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017033", 
        "issn": [
          "0003-2417", 
          "1432-055X"
        ], 
        "name": "Der Anaesthesist", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "57"
      }
    ], 
    "keywords": [
      "coronary artery disease", 
      "heart rate control", 
      "cardiac function", 
      "alone group", 
      "continuous infusion", 
      "perioperative beta-blocker therapy", 
      "phosphodiesterase-III inhibitor enoximone", 
      "vascular surgery patients", 
      "beta-blocker therapy", 
      "high-risk patients", 
      "pulmonary artery catheter", 
      "plasma BNP concentration", 
      "type natriuretic peptide", 
      "blocker therapy", 
      "cardiac index", 
      "risk patients", 
      "surgery patients", 
      "artery disease", 
      "artery catheter", 
      "BNP concentrations", 
      "natriuretic peptide", 
      "vascular surgery", 
      "serial measurements", 
      "esmolol", 
      "heart rate", 
      "patients", 
      "enoximone", 
      "observation period", 
      "infusion", 
      "therapy", 
      "detectable levels", 
      "group", 
      "surgery", 
      "catheter", 
      "cTnT", 
      "disease", 
      "rate control", 
      "period", 
      "control", 
      "rate", 
      "function", 
      "aim", 
      "peptides", 
      "und B", 
      "combination", 
      "index", 
      "levels", 
      "study", 
      "concentration", 
      "use", 
      "higher values", 
      "target rate", 
      "values", 
      "measurements", 
      "PDE"
    ], 
    "name": "Kontinuierliche \u03b2-Blockade mit Esmolol in Kombination mit Enoximon-Gabe", 
    "pagination": "231-241", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051434526"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00101-008-1313-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18270676"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00101-008-1313-2", 
      "https://app.dimensions.ai/details/publication/pub.1051434526"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-06-01T22:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_459.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00101-008-1313-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00101-008-1313-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00101-008-1313-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00101-008-1313-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00101-008-1313-2'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      21 PREDICATES      103 URIs      95 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00101-008-1313-2 schema:about N028e6db779c04106ba4ace019706ca29
2 N0a8c8647f41c4eb9af9c45412758b50e
3 N173ee6e011b64080a210bb756a5ec547
4 N2c9d795e691541b5878643d674b3ca7a
5 N310e979ad1394a09ac3564b368b9faf1
6 N32e769997e1646d995f7eafcceba97aa
7 N4a9bed5683154524bdee1afed39d2096
8 N5c074bc1ebe74a68a09d3e17f6837b6a
9 N5d1db75e05dd4ab3a2b7918f9324f3a4
10 N6286873ec5c24377bf31ac78238d053c
11 N68c8e3805ec0403bbe8a895bfe1a3735
12 N8042fd36474c4a54b51f91f0550e9a47
13 N8c5058ac53874ac78e0e6e9cb72f89a4
14 N95a35a511afa429bb5a45e41db65b02b
15 N969e2597d0634391ae342f6b415245b3
16 Nc790a08f5a4a4bc28bd6b677145d447d
17 Nce22346c01db4854a50134e55b1a301f
18 Nd41cf04c5f404cd1931b239abf059098
19 Ne07ab5d86b354689bad512250b5e41b3
20 Nefb93f3711f74863a0502e3ad76408eb
21 Nf1e3892671994c4dbe415e3d2fa17533
22 Nf892f8e9866b4ba58f7c0073da947f54
23 anzsrc-for:11
24 anzsrc-for:1102
25 schema:author Neff292817bdb463084f438588d40b79e
26 schema:datePublished 2008-02-14
27 schema:datePublishedReg 2008-02-14
28 schema:description BackgroundThe aim of this study was to assess cardiac function in vascular surgery patients with known coronary artery disease (CAD) who received continuous perioperative beta blocker therapy with esmolol alone versus esmolol in combination with the phosphodiesterase (PDE) III inhibitor enoximone.Patients and methodsOver a period of 24 h, 28 patients were assigned to receive heart rate (HR) control by continuous infusion of esmolol in combination with the PDE III inhibitor enoximone (Esmolol+Enoximone group) or esmolol alone (Esmolol group; n=14). Cardiac function was assessed by the use of a pulmonary artery catheter and serial measurements of plasma troponin T (TnT) und B-type natriuretic peptide (BNP).ResultsThe heart rate significantly decreased to the target rate of 50–60 min−1 in both groups over the observation period. Cardiac index increased significantly only in Esmolol+Enoximone-treated patients (from 2.4±0.2 l×min−1×m−2 to 3.1±0.1 l×min−1×m−2) and was significantly higher than in the esmolol alone group (from 2.5±0.2 l×min−1×m−2 to 2.4±0.1 l×min−1×m−2). No patient had detectable levels of cTnT perioperatively. Peak plasma BNP concentrations were significantly increased in both groups but the highest values were measured in the esmolol alone group.ConclusionInotropic therapy with the PDE III inhibitor enoximone improves cardiac function in high risk patients with known CAD undergoing vascular surgery and also when receiving systematic heart rate control by continuous infusion of esmolol.
29 schema:genre article
30 schema:inLanguage de
31 schema:isAccessibleForFree false
32 schema:isPartOf N1bb9137846aa4c1980923ecbbef59880
33 N722cf14f1b6b45e6857613543ff642b1
34 sg:journal.1017033
35 schema:keywords BNP concentrations
36 PDE
37 aim
38 alone group
39 artery catheter
40 artery disease
41 beta-blocker therapy
42 blocker therapy
43 cTnT
44 cardiac function
45 cardiac index
46 catheter
47 combination
48 concentration
49 continuous infusion
50 control
51 coronary artery disease
52 detectable levels
53 disease
54 enoximone
55 esmolol
56 function
57 group
58 heart rate
59 heart rate control
60 high-risk patients
61 higher values
62 index
63 infusion
64 levels
65 measurements
66 natriuretic peptide
67 observation period
68 patients
69 peptides
70 period
71 perioperative beta-blocker therapy
72 phosphodiesterase-III inhibitor enoximone
73 plasma BNP concentration
74 pulmonary artery catheter
75 rate
76 rate control
77 risk patients
78 serial measurements
79 study
80 surgery
81 surgery patients
82 target rate
83 therapy
84 type natriuretic peptide
85 und B
86 use
87 values
88 vascular surgery
89 vascular surgery patients
90 schema:name Kontinuierliche β-Blockade mit Esmolol in Kombination mit Enoximon-Gabe
91 schema:pagination 231-241
92 schema:productId N703cbc6eba2d467eb2e67fb752e431b1
93 Nb38b2b377dc24aa99c3bdef19c4d4624
94 Nb71c9eb41f26484a99766fc388e7047a
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051434526
96 https://doi.org/10.1007/s00101-008-1313-2
97 schema:sdDatePublished 2022-06-01T22:05
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher Nc3c3ef7a7b664a5c9ef52b8284e740cd
100 schema:url https://doi.org/10.1007/s00101-008-1313-2
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N028e6db779c04106ba4ace019706ca29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 N0a8c8647f41c4eb9af9c45412758b50e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Heart Rate
109 rdf:type schema:DefinedTerm
110 N173ee6e011b64080a210bb756a5ec547 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Propanolamines
112 rdf:type schema:DefinedTerm
113 N1bb9137846aa4c1980923ecbbef59880 schema:volumeNumber 57
114 rdf:type schema:PublicationVolume
115 N279afd10a6814ed98e0c91352d98958e schema:affiliation grid-institutes:grid.413225.3
116 schema:familyName Suttner
117 schema:givenName S.
118 rdf:type schema:Person
119 N2c9d795e691541b5878643d674b3ca7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Heart
121 rdf:type schema:DefinedTerm
122 N310e979ad1394a09ac3564b368b9faf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Phosphodiesterase Inhibitors
124 rdf:type schema:DefinedTerm
125 N32e769997e1646d995f7eafcceba97aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Atrial Natriuretic Factor
127 rdf:type schema:DefinedTerm
128 N439d75167d71496ab1662dbbeb9546bf rdf:first sg:person.01177053013.87
129 rdf:rest Nf53182f672c0454787e51c69fa5dae20
130 N4a9bed5683154524bdee1afed39d2096 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Coronary Artery Disease
132 rdf:type schema:DefinedTerm
133 N5c074bc1ebe74a68a09d3e17f6837b6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Electrocardiography
135 rdf:type schema:DefinedTerm
136 N5d1db75e05dd4ab3a2b7918f9324f3a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Enoximone
138 rdf:type schema:DefinedTerm
139 N6286873ec5c24377bf31ac78238d053c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Drug Therapy, Combination
141 rdf:type schema:DefinedTerm
142 N68c8e3805ec0403bbe8a895bfe1a3735 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Cardiotonic Agents
144 rdf:type schema:DefinedTerm
145 N703cbc6eba2d467eb2e67fb752e431b1 schema:name doi
146 schema:value 10.1007/s00101-008-1313-2
147 rdf:type schema:PropertyValue
148 N722cf14f1b6b45e6857613543ff642b1 schema:issueNumber 3
149 rdf:type schema:PublicationIssue
150 N7788c85059b3474d8d5b78237135f5ce rdf:first sg:person.0737003120.38
151 rdf:rest rdf:nil
152 N8042fd36474c4a54b51f91f0550e9a47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Adrenergic beta-Antagonists
154 rdf:type schema:DefinedTerm
155 N8c5058ac53874ac78e0e6e9cb72f89a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Monitoring, Intraoperative
157 rdf:type schema:DefinedTerm
158 N95a35a511afa429bb5a45e41db65b02b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Troponin T
160 rdf:type schema:DefinedTerm
161 N969e2597d0634391ae342f6b415245b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Aged
163 rdf:type schema:DefinedTerm
164 Nb38b2b377dc24aa99c3bdef19c4d4624 schema:name pubmed_id
165 schema:value 18270676
166 rdf:type schema:PropertyValue
167 Nb71c9eb41f26484a99766fc388e7047a schema:name dimensions_id
168 schema:value pub.1051434526
169 rdf:type schema:PropertyValue
170 Nc3c3ef7a7b664a5c9ef52b8284e740cd schema:name Springer Nature - SN SciGraph project
171 rdf:type schema:Organization
172 Nc790a08f5a4a4bc28bd6b677145d447d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Male
174 rdf:type schema:DefinedTerm
175 Nce22346c01db4854a50134e55b1a301f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Risk
177 rdf:type schema:DefinedTerm
178 Nd41cf04c5f404cd1931b239abf059098 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Anesthesia
180 rdf:type schema:DefinedTerm
181 Nd74ba50f49604d0fbbc786de9105041f rdf:first sg:person.01114147735.99
182 rdf:rest N439d75167d71496ab1662dbbeb9546bf
183 Nd79609b3b4124234881ddf038af50b0d rdf:first sg:person.01230376335.52
184 rdf:rest Nd74ba50f49604d0fbbc786de9105041f
185 Ne07ab5d86b354689bad512250b5e41b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Vascular Surgical Procedures
187 rdf:type schema:DefinedTerm
188 Nefb93f3711f74863a0502e3ad76408eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Middle Aged
190 rdf:type schema:DefinedTerm
191 Neff292817bdb463084f438588d40b79e rdf:first N279afd10a6814ed98e0c91352d98958e
192 rdf:rest Nd79609b3b4124234881ddf038af50b0d
193 Nf1e3892671994c4dbe415e3d2fa17533 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Heart Function Tests
195 rdf:type schema:DefinedTerm
196 Nf53182f672c0454787e51c69fa5dae20 rdf:first sg:person.0770704460.58
197 rdf:rest N7788c85059b3474d8d5b78237135f5ce
198 Nf892f8e9866b4ba58f7c0073da947f54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Female
200 rdf:type schema:DefinedTerm
201 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
202 schema:name Medical and Health Sciences
203 rdf:type schema:DefinedTerm
204 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
205 schema:name Cardiorespiratory Medicine and Haematology
206 rdf:type schema:DefinedTerm
207 sg:journal.1017033 schema:issn 0003-2417
208 1432-055X
209 schema:name Der Anaesthesist
210 schema:publisher Springer Nature
211 rdf:type schema:Periodical
212 sg:person.01114147735.99 schema:affiliation grid-institutes:grid.413225.3
213 schema:familyName Lang
214 schema:givenName K.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114147735.99
216 rdf:type schema:Person
217 sg:person.01177053013.87 schema:affiliation grid-institutes:grid.413225.3
218 schema:familyName Mayer
219 schema:givenName J.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177053013.87
221 rdf:type schema:Person
222 sg:person.01230376335.52 schema:affiliation grid-institutes:grid.413225.3
223 schema:familyName Boldt
224 schema:givenName J.
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230376335.52
226 rdf:type schema:Person
227 sg:person.0737003120.38 schema:affiliation grid-institutes:grid.413225.3
228 schema:familyName Piper
229 schema:givenName S.N.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737003120.38
231 rdf:type schema:Person
232 sg:person.0770704460.58 schema:affiliation grid-institutes:grid.413225.3
233 schema:familyName Röhm
234 schema:givenName K.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770704460.58
236 rdf:type schema:Person
237 grid-institutes:grid.413225.3 schema:alternateName Klinik für Anästhesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland
238 schema:name Klinik für Anästhesie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen, Bremser Str. 79, 67063, Ludwigshafen, Deutschland
239 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...